OR7E121P

Across TCGA pan-cancer cohorts, OR7E121P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated OR7E121P data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher OR7E121P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E121P expression acts as an unfavorable survival marker, although some lineages such as UVM and OV show a favorable association.

SKCM, THCA, and LIHC are the cancer types where OR7E121P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	II,III,IV	0.090	0.356	.003	69	view →
THCA	DFS	Tertile	II,III,IV	0.795	0.920	<.001	51	view →
LIHC	OS	Tertile	III,IV	0.185	0.654	.005	48	view →
UVM	DFS	Tertile	III,IV	0.816	0.327	.010	27	view →
LUSC	OS	Tertile	II,III,IV	0.285	0.711	.002	27	view →
KICH	OS	Tertile	All	0.929	1.000	.028	24	view →
LUAD	DFS	Tertile	II,III,IV	0.285	0.594	.002	21	view →
CESC	DFS	Tertile	III,IV	0.272	0.658	.023	18	view →
PCPG	OS	Tertile	All	0.828	0.963	<.001	18	view →
OV	OS	Median	IV	0.727	0.558	.017	14	view →
READ	DFS	Median	III,IV	0.512	0.194	.004	13	view →
KIRC	DFS	Tertile	III,IV	0.284	0.484	.028	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

OR7E121P–SKCM (OS)

Open the SKCM breakdown →